This is a repub of a blog post I wrote Feb 27, 2016 The falling costs in DNA, first from PCR (polymerase chain reaction) and then from sequencing, has driven an amazing drop in cost of doing business in biotechnology. Plus, the earlier generations of basic tools have come out…